Search Results - A.M. Jegg

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    PB2112: MINDWAY: A PHASE IB/II DOSE OPTIMIZATION STUDY TO ASSESS SAFETY AND PHARMACOKINETICS OF TAFASITAMAB + LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL... by R. Greil, K. Kopeckova, L. Arcaini, A. Amin, K. de Graaf, A.-M. Jegg

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    B03 | PELABRESIB IN COMBINATION WITH RUXOLITINIB FOR JANUS KINASE INHIBITOR-NAIVE PATIENTS WITH MYELOFIBROSIS: 72-WEEK FOLLOW-UP WITH LONG-TERM EFFICACY OUTCOMES OF THE PHASE III M... by A. Vannucchi, R. Rampal, D. Chraniuk, S. Grosicki, E. Abruzzese, S. Lee, A. Lucchesi, A. Gerds, S. Oh, A. Patriarca, A. Álvarez Larrán, D. Lavie, V. Gupta, A. Kuykendall, P. Bose, M. Talpaz, F. Palandri, R. Mesa, J.J. Kiladjian, M. Wroclawska, M. Wu, A.M. Jegg, J. Mascarenhas, C. Harrison

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: